Stock Market & Financial Investment News

News Breaks February 4, 2013 12:27 EDT JNJ FDA says approval of generic Doxil expected to help resolve shortage The U.S. Food and Drug Administration announced it approved the first generic version of the cancer drug Doxil, which is currently on the FDA’s drug shortage list. The generic is made by Sun Pharma Global FZE and will be available in 20 milligram and 50 milligram vials. In February 2012, to address the shortage of doxorubicin hydrochloride liposome injection, the FDA announced it would exercise enforcement discretion for temporary controlled importation of Lipodox, an alternative to Doxil produced by Sun and its authorized distributor, Caraco Pharmaceutical Laboratories that is not approved in the United States. Enforcement discretion was also used to release one lot of Janssen’s Doxil made under an unapproved manufacturing process. Janssen is a unit of Johnson & Johnson (JNJ). News For JNJ From The Last 14 Days Check below for free stories on JNJ the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 06:19 EDT JNJ J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports Subscribe for More Information May 15, 2013 16:51 EDT JNJ FDA approves Simponi to treat ulcerative colitis Subscribe for More Information May 10, 2013 11:48 EDT JNJ Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information 06:16 EDT JNJ Obesity surgery booming in India, Bloomberg reports Subscribe for More Information May 9, 2013 17:09 EDT JNJ Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link 09:51 EDT JNJ J&J unit says first patient enrolled in reMARQable study Subscribe for More Information May 8, 2013 07:38 EDT JNJ BofA/Merrill's medical tech analyst hold an analyst/industry conference call Subscribe for More Information May 6, 2013 11:29 EDT JNJ J&J cosmetics license revoked at Mumbai plant, Reuters says Subscribe for More Information 07:24 EDT JNJ Drug companies attempt to make painkillers that can't be abused, WSJ reports Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.